Studies highlight that antibiotic use is prevalent in outpatient and inpatient settings in the United States. Ceftriaxone, a broad-spectrum antibiotic, is effective in treating a wide range of bacterial infections, including those in the respiratory tract, skin, soft tissues, bones, joints, bloodstream, and central nervous system.
As antibiotic resistance continues to rise, prescribing and using antibiotics responsibly becomes
increasingly important. Understanding ceftriaxone's indications, safety profile, and dosage recommendations helps optimize its benefits while minimizing the risks of resistance and adverse outcomes.
[signup]
What Is Ceftriaxone Sodium?
Ceftriaxone belongs to a group of medications called cephalosporin antibiotics, which are used to treat many types of bacterial infections. It is administered as an injection into a vein or a muscle, so it is most commonly used in a clinical setting rather than prescribed for at-home use.
Definition and Classification
Cephalosporins are classified into generations based on their spectrum of coverage against various bacterial strains. Ceftriaxone is a third-generation cephalosporin with broad-spectrum activity against gram-positive and gram-negative bacteria.
Like other cephalosporin antibiotics, ceftriaxone has a unique chemical structure that helps it fight bacteria. It contains a six-membered ring called dihydrothiazine attached to a beta-lactam ring. These rings work together to interfere with bacterial cell wall formation, ultimately stopping bacteria from growing.
History and Development
The first cephalosporin antibiotic was discovered by Italian scientist Giuseppe Brotzu in 1945. Ceftriaxone, specifically, was developed in 1978 and approved by the U.S. Food and Drug Administration (FDA) in 1984, marketed under the brand name Rocephin, as a third-generation cephalosporin antibiotic to treat bacterial infections, such as those affecting the lungs, middle ear, skin, and urinary tract.
Medical Uses of Ceftriaxone Sodium
The FDA has approved ceftriaxone to treat the following infections caused by susceptible bacteria:
- Lower respiratory tract infections
- Acute otitis media (middle ear infection)
- Skin infections
- Urinary tract infections (UTIs)
- Uncomplicated gonorrhea (cervical, urethral, rectal, or pharyngeal)
- Pelvic inflammatory disease (PID)
- Bacterial septicemia (an infection where bacteria enter the bloodstream)
- Bone and joint infections
- Intra-abdominal infections
- Meningitis
- Surgical prophylaxis of postoperative infections
Susceptible bacteria include:
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Staphylococcus aureus
- Staphylococcus epidermidis
- Haemophilus influenzae
- Haemophilus parainfluenzae
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Escherichia coli
- Enterobacter aerogenes
- Enterobacter cloacae
- Proteus mirabilis
- Proteus vulgaris
- Serratia marcescens
- Moraxella catarrhalis
- Morganella morganii
- Pseudomonas aeruginosa
- Acinetobacter calcoaceticus
- Bacteroides fragilis
- Peptostreptococcus spp.
- Neisseria gonorrhoeae
- Neisseria meningitidis
Dosage and Administration
Ceftriaxone is administered into the muscle (intramuscularly) or a vein (intravenously).
The dose will depend on the patient's age and the condition being treated. Below are general dosage recommendations.
Pediatric Patients
- Skin and Skin Structure Infections: 50-75 mg/kg once daily (or equally divided doses twice a day). Do not exceed a total daily dose of 2 grams.
- Acute Bacterial Otitis Media: a single dose of 50 mg/kg. Do not exceed a total dose of 1 gram.
- Serious Miscellaneous Infections Other Than Meningitis: 50-75 mg/kg daily, given in divided doses every 12 hours. Do not exceed a total daily dose of 2 grams.
- Meningitis: 100 mg/kg (not exceeding 4 grams) per day, given once daily or in equally divided doses every 12 hours for 7-14 days.
Adult Patients
- Most Infections: 1-2 grams given once daily (or in equally divided doses twice daily) for 4-14 days. Therapy should be continued for at least two days after the signs and symptoms of infection have disappeared.
- Uncomplicated Gonococcal Infections: a single intramuscular dose of 250 mg
- Surgical Prophylaxis: a single intravenous dose of 1 gram administered 30 minutes to 2 hours before surgery
- Streptococcus pyogenes Infections: therapy should be continued for at least 10 days
Pharmacology of Ceftriaxone Sodium
Let's take a closer look at how ceftriaxone works in the body.
Mechanism of Action
Bacteria build a strong cell wall by creating an outer layer of cross-linked peptidoglycans (long chains of sugars and amino acids). Ceftriaxone's beta-lactam ring binds to penicillin-binding proteins (PBPs), which are responsible for the cross-linking of peptidoglycans.
When this happens, the PBPs can no longer do their job, preventing the bacteria from properly assembling their cell walls. Bacteria cannot maintain their shape or protect themselves from bursting without a functional cell wall. As a result, the bacteria are destroyed due to the buildup of internal pressure, and they die.
Pharmacokinetics
Ceftriaxone is poorly absorbed in the gastrointestinal (GI) tract, so it is only administered intravenously or intramuscularly.
Once in the bloodstream, it is widely distributed throughout the body, including the cerebrospinal fluid, making it an effective agent for treating meningitis. It can also cross the placenta and is present in high concentrations in the liquid (synovial fluid) found in joint spaces.
Ceftriaxone is metabolized and eliminated from the body through both hepatobiliary (liver) and renal (kidneys) pathways. Up to two-thirds of the drug is excreted unchanged in the urine, while the remainder is secreted as inactive compounds in the bile and ultimately eliminated in the feces.
Side Effects and Safety
Ceftriaxone is generally well tolerated, but adverse reactions can occur. Always contact your doctor immediately if any concerning symptoms arise.
Mild Side Effects
- Local Reactions: pain and tenderness at the injection site (1%)
- Allergy: rash (1.7%)
- Hematologic: increased eosinophils (6%), increased platelets (5.1%), low white blood cells (2.1%)
- Gastrointestinal: diarrhea (2.7%), nausea and vomiting (<1%), elevated liver enzymes (3.1-3.3%), abdominal pain (<0.1%)
- Genitourinary: elevated BUN (1.2%), vaginitis (<1%)
- Neurological: headache or dizziness (<1%)
Serious Adverse Effects
- Neurological: altered conscious state, confusion, seizures, involuntary muscle spasms
- Gastrointestinatridioises difficile-associated diarrhea
- Hematological: immune-mediated hemolytic anemia (destruction of red blood cells)
Precautions and Contraindications
Ceftriaxone may not be safe or appropriate for everyone. Precautions should be taken for certain populations to minimize the risk of adverse effects.
- Prescribing ceftriaxone in the absence of a proven or strongly suspected bacterial infection or surgical prophylaxis increases the risk of antibiotic drug resistance.
- The total daily dosage should not exceed 2 grams in patients with liver dysfunction and significant kidney disease. If ceftriaxone is used, patients should be monitored closely for side effects.
- Patients with kidney/liver impairment, poor nutritional state, receiving an extended course of antibiotics, and those on anticoagulant therapy are at an increased risk of bleeding. Prothrombin time (PT) should be monitored in at-risk patients, and vitamin K should be administered as indicated by prolonged PT activity.
- Patients with a history of GI disease, especially colitis, may be at an increased risk of pseudomembranous colitis (inflammation of the colon caused by an overgrowth of Clostridioides difficile).
- Discontinue ceftriaxone if patients develop signs and symptoms of gallbladder disease.
- Monitor patients with risk factors for biliary stasis and biliary sludge for signs of pancreatitis.
- Because there are no well-controlled studies in pregnant women, the potential for increased fetal risk cannot be ruled out, and ceftriaxone should only be used during pregnancy when clearly indicated.
Contraindications are specific situations in which a person should not take medication due to safety concerns. Ceftriaxone is contraindicated in the following populations:
- Patients with known allergy to ceftriaxone, other cephalosporins, penicillins, or beta-lactam antibiotics
- Premature newborns
Drug Interactions
A drug-drug interaction occurs when the effect of one drug is altered by the presence of another drug, either increasing or decreasing the effect of one or both drugs or causing unexpected side effects.
The lists below do not include all possible drug interactions with ceftriaxone. Always give your doctor a list of medications and supplements that you are currently taking to avoid drug-drug interactions.
When ceftriaxone is combined with calcium, it can lead to the formation of solid particles. Ceftriaxone should not be mixed with the following calcium-containing solutions:
- Calcium acetate
- Calcium chloride
- Calcium gluceptate
- Calcium gluconate
- Lactated ringer's solution
Other major interactions include:
- Live Cholera Vaccine: If administered simultaneously, ceftriaxone can reduce the vaccine's effectiveness.
- Warfarin: Ceftriaxone can enhance warfarin's blood-thinning effects, increasing the risk of bleeding complications.
Considerations and Alternatives
The Centers for Disease Control and Prevention (CDC) warns that antibiotic resistance is a growing public health challenge. Antibiotic resistance refers to the ability of bacteria to withstand the effects of antibiotics, rendering these medications ineffective in treating bacterial infections.
Mechanisms for growing antibiotic resistance include:
- Antibiotic overuse
- Inappropriate prescribing of antibiotics
- Extensive agricultural use of antibiotics
Methicillin-resistant staphylococci are resistant to cephalosporins, including ceftriaxone. Most strains of Group D streptococci and enterococci are also resistant. Neisseria gonorrhoeae resistance to ceftriaxone is a growing concern globally.
Antibiotic stewardship is a multifaceted approach aimed at promoting the responsible and judicious use of antibiotics to minimize the risk of antibiotic resistance:
- Only take ceftriaxone to treat bacterial infections caused by susceptible organisms.
- Do not skip antibiotic doses or discontinue therapy before completing the entire course as prescribed by your doctor.
- Prevent infections through proper hygiene, vaccination, and safe food handling.
When ceftriaxone is contraindicated, alternative antibiotics can be considered based on the specific infection being treated. Examples include:
- Gentamicin for urogenital or rectal gonorrhea
- Vancomycin or daptomycin for methicillin-resistant Staphylococcus aureus (MRSA)
- Amoxicillin for acute otitis media
[signup]
Key Takeaways
- Ceftriaxone is a third-generation cephalosporin antibiotic widely used to treat bacterial infections, given its broad spectrum of activity.
- While generally well tolerated and safe when used as prescribed, specific populations may be at a higher risk for adverse effects. Always talk to your doctor about known allergies, health conditions, and medications/supplements you are taking to prevent side effects.
- Responsible antibiotic usage is vital to prevent the rise of antibiotic-resistant bacteria. Never use ceftriaxone to treat an infection without consulting a healthcare provider.
%201.svg){kind=logo}
